"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
Luxiq (betamethasone valerate foam) is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
DOSAGE AND ADMINISTRATION
Note: For proper dispensing of foam, can must be inverted.
For application to the scalp invert can and dispense a small amount of Luxiq (betamethasone valerate foam) onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Luxiq (betamethasone valerate foam) should not be used with occlusive dressings unless directed by a physician.
Luxiq (betamethasone valerate foam) is supplied in 150 gram (NDC 63032-021-01), 100 gram (NDC 63032-021-00) and 50 gram (NDC 63032-021-50) aluminum cans.
Store at controlled room temperature 68-77°F (20-25°C).
FLAMMABLE. AVOID FIRE, FLAME OR SMOKING DURING AND IMMEDIATELY FOLLOWING APPLICATION. Keep out of reach of children. Contents under pressure. Do not puncture or incinerate container. Do not expose to heat or store at temperatures above 120°F (49°C).
Manufactured for Stiefel Laboratories, Inc., Coral Gables, FL 33134, USA. For additional information: 1-888-500-DERM or visit www.luxiq (betamethasone valerate foam) .com. FDA Rev date: 7/11/2006This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/29/2008
Additional Luxiq Information
Luxiq - User Reviews
Luxiq User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.